Ratings Ryan Specialty Holdings, Inc.

Equities

RYAN

US78351F1075

Market Closed - Nyse 04:00:02 2024-06-07 pm EDT 5-day change 1st Jan Change
53.85 USD -1.37% Intraday chart for Ryan Specialty Holdings, Inc. -3.03% +25.17%

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 62% by 2026.
  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

Weaknesses

  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 51.09 times its estimated earnings per share for the ongoing year.
  • The company appears highly valued given the size of its balance sheet.
  • The company is not the most generous with respect to shareholders' compensation.
  • For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
  • The overall consensus opinion of analysts has deteriorated sharply over the past four months.
  • Over the past twelve months, analysts' opinions have been revised negatively.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Multiline Insurance & Brokers

1st Jan change Capi. Investor Rating ESG Refinitiv
+25.17% 6.41B -
-2.71% 61.56B
C
+5.92% 26.12B
C+
+26.96% 25.75B
C
+12.64% 8.27B -
-4.64% 4.03B
B
0.00% 3.73B - -
+13.15% 2.39B
C+
+42.34% 2.26B
C-
-18.81% 1.55B
C-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. RYAN Stock
  4. Ratings Ryan Specialty Holdings, Inc.